WO2004003011A3 - Recepteur hormonal nucleaire - Google Patents

Recepteur hormonal nucleaire Download PDF

Info

Publication number
WO2004003011A3
WO2004003011A3 PCT/GB2003/002808 GB0302808W WO2004003011A3 WO 2004003011 A3 WO2004003011 A3 WO 2004003011A3 GB 0302808 W GB0302808 W GB 0302808W WO 2004003011 A3 WO2004003011 A3 WO 2004003011A3
Authority
WO
WIPO (PCT)
Prior art keywords
hormone receptor
nuclear hormone
protein
termed
diagnosis
Prior art date
Application number
PCT/GB2003/002808
Other languages
English (en)
Other versions
WO2004003011A2 (fr
Inventor
Christopher Benjamin Phelps
Mark Alistair Farrow
Richard Joseph Fagan
Janet Marjorie Allen
Kathryn Elizabeth Allen
Ilana Stancovski
Valerie Nathalie Pierron
Tom Phillips
Caroline Ann Hunt
Zinat Ellaheh Enayat
Christopher Michael J Williams
Original Assignee
Inpharmatica Ltd
Christopher Benjamin Phelps
Mark Alistair Farrow
Richard Joseph Fagan
Janet Marjorie Allen
Kathryn Elizabeth Allen
Ilana Stancovski
Valerie Nathalie Pierron
Tom Phillips
Caroline Ann Hunt
Zinat Ellaheh Enayat
Christopher Michael J Williams
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inpharmatica Ltd, Christopher Benjamin Phelps, Mark Alistair Farrow, Richard Joseph Fagan, Janet Marjorie Allen, Kathryn Elizabeth Allen, Ilana Stancovski, Valerie Nathalie Pierron, Tom Phillips, Caroline Ann Hunt, Zinat Ellaheh Enayat, Christopher Michael J Williams filed Critical Inpharmatica Ltd
Priority to EP03761713A priority Critical patent/EP1519955A2/fr
Priority to AU2003242849A priority patent/AU2003242849A1/en
Publication of WO2004003011A2 publication Critical patent/WO2004003011A2/fr
Publication of WO2004003011A3 publication Critical patent/WO2004003011A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention se rapporte à une protéine, appelée BAB47423.1, identifiée dans la description comme récepteur hormonal nucléaire. L'invention se rapporte également à l'utilisation de cette protéine et d'une séquence d'acide nucléique du gène codant dans le diagnostic, la prévention et le traitement de maladies.
PCT/GB2003/002808 2002-07-01 2003-07-01 Recepteur hormonal nucleaire WO2004003011A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP03761713A EP1519955A2 (fr) 2002-07-01 2003-07-01 Recepteur hormonal nucleaire
AU2003242849A AU2003242849A1 (en) 2002-07-01 2003-07-01 Nuclear hormone receptor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0215226.2A GB0215226D0 (en) 2002-07-01 2002-07-01 Protein
GB0215226.2 2002-07-01

Publications (2)

Publication Number Publication Date
WO2004003011A2 WO2004003011A2 (fr) 2004-01-08
WO2004003011A3 true WO2004003011A3 (fr) 2004-03-25

Family

ID=9939655

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2003/002808 WO2004003011A2 (fr) 2002-07-01 2003-07-01 Recepteur hormonal nucleaire

Country Status (4)

Country Link
EP (1) EP1519955A2 (fr)
AU (1) AU2003242849A1 (fr)
GB (1) GB0215226D0 (fr)
WO (1) WO2004003011A2 (fr)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1074617A2 (fr) * 1999-07-29 2001-02-07 Helix Research Institute Amorces pour la synthèse de cADN de pleine longueur et leur utilisation
WO2001009318A1 (fr) * 1999-07-29 2001-02-08 Helix Research Institute Genes associes au cancer du foie
CN1352259A (zh) * 2000-11-06 2002-06-05 上海博德基因开发有限公司 一种新的多肽——蝶呤钼氧化还原酶126.39和编码这种多肽的多核苷酸
WO2002052005A1 (fr) * 2000-12-22 2002-07-04 Kazusa Dna Research Institute Foundation Genes et proteines codees par ceux-ci
WO2002083921A2 (fr) * 2001-04-10 2002-10-24 Agensys, Inc. Acides nucleiques et proteines correspondantes utiles pour la detection et le traitement de divers cancers
JP2002345492A (ja) * 2002-02-26 2002-12-03 Kazusa Dna Kenkyusho 新規遺伝子及びそれにコードされる蛋白質

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1074617A2 (fr) * 1999-07-29 2001-02-07 Helix Research Institute Amorces pour la synthèse de cADN de pleine longueur et leur utilisation
WO2001009318A1 (fr) * 1999-07-29 2001-02-08 Helix Research Institute Genes associes au cancer du foie
CN1352259A (zh) * 2000-11-06 2002-06-05 上海博德基因开发有限公司 一种新的多肽——蝶呤钼氧化还原酶126.39和编码这种多肽的多核苷酸
WO2002052005A1 (fr) * 2000-12-22 2002-07-04 Kazusa Dna Research Institute Foundation Genes et proteines codees par ceux-ci
WO2002083921A2 (fr) * 2001-04-10 2002-10-24 Agensys, Inc. Acides nucleiques et proteines correspondantes utiles pour la detection et le traitement de divers cancers
JP2002345492A (ja) * 2002-02-26 2002-12-03 Kazusa Dna Kenkyusho 新規遺伝子及びそれにコードされる蛋白質

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] XP002261890, retrieved from EBI Database accession no. Q96JN1 *
DATABASE EMBL [online] XP002262190, retrieved from EBI Database accession no. ABR01791 *
DATABASE EMBL [online] XP002262191, retrieved from EBI Database accession no. ABR01831 *
DATABASE EMBL [online] XP002267056, retrieved from EBI Database accession no. BD585294 *
MCDONNELL D P ET AL: "NUCLEAR HORMONE RECEPTORS AS TARGETS FOR NEW DRUG DISCOVERY", BIO/TECHNOLOGY, NATURE PUBLISHING CO. NEW YORK, US, vol. 11, 1 November 1993 (1993-11-01), pages 1256 - 1261, XP002018219, ISSN: 0733-222X *
NAGASE T ET AL: "PREDICTION OF THE CODING SEQUENCES OF UNIDENTIFIED HUMAN GENES. XX.THE COMPLETE SEQUENCES OF 100 NEW CDNA CLONES FROM BRAIN WHICH CODE FOR LARGE PROTEINS IN VITRO", DNA RESEARCH, UNIVERSAL ACADEMY PRESS, JP, vol. 8, no. 2, q96jn1, 2001, pages 85 - 95, XP001030942, ISSN: 1340-2838, Retrieved from the Internet <URL:EMBL> *
SCHAPIRA M ET AL: "Rational discovery of novel nuclear hormone receptor antagonists", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 97, no. 3, 1 February 2000 (2000-02-01), pages 1008 - 1013, XP002170486, ISSN: 0027-8424 *

Also Published As

Publication number Publication date
AU2003242849A8 (en) 2004-01-19
AU2003242849A1 (en) 2004-01-19
EP1519955A2 (fr) 2005-04-06
GB0215226D0 (en) 2002-08-14
WO2004003011A2 (fr) 2004-01-08

Similar Documents

Publication Publication Date Title
WO2003054012A3 (fr) Leptines
WO2006046073A3 (fr) Proteine du type c1q
WO2004096856A3 (fr) Famille de proteines secretees
WO2006016172A3 (fr) Glycoproteine de surface
WO2002070563A3 (fr) Domaine de liaison de ligand au recepteur hormonal nucleaire
IL169256A0 (en) Metalloprotease proteins
WO2004003011A3 (fr) Recepteur hormonal nucleaire
NO20052525D0 (no) Spleisevariant av humant hypofyseveksthormon
WO2004009633A8 (fr) Recepteur de serotonine
WO2002070558A3 (fr) Domaine de liaison du ligand du recepteur hormonal nucleaire
WO2004005346A3 (fr) Recepteur de l&#39;hormone nucleaire
WO2004101618A3 (fr) Proteines associees au recepteur de progestine yol002c-cgi-45
WO2004053117A3 (fr) Serine protease
WO2002033058A3 (fr) Proteases a cysteine
WO2004000882A3 (fr) Proteines
WO2004056863A8 (fr) Variante d&#39;epissage
WO2004003010A3 (fr) Recepteur hormonal nucleaire
WO2004024762A3 (fr) Proteine de type il-8
WO2004016654A8 (fr) Proteine du type il-8
WO2002046380A3 (fr) Proteine kinase
WO2004026905A3 (fr) Proteines de transport/canal
WO2004011648A3 (fr) Cytochromes p450
WO2002062845A3 (fr) Molecules d&#39;adhesion
WO2002044382A8 (fr) Proteines de cytokine
WO2002034901A8 (fr) Proteine kinase

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003761713

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003761713

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2003761713

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP